The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach

NATURE REVIEWS CLINICAL ONCOLOGY

Cornelissen, JJ; Gratwohl, A; Schlenk, RF; Sierra, J; Bornhauser, M; Juliusson, G; Racil, Z; Rowe, JM; Russell, N; Mohty, M; Lowenberg, B; Socie, G; Niederwieser, D; Ossenkoppele, GJ, 2012: The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach. NATURE REVIEWS CLINICAL ONCOLOGY 9(10), p. 579 - 590, doi: 10.1038/nrclinonc.2012.150